z-logo
open-access-imgOpen Access
A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer
Author(s) -
Kristin M. Sheffield,
Jessica Peachey,
Michael Method,
Brenda R. Grimes,
Jacqueline Brown,
Kim Saverno,
Tomoko Sugihara,
Zhanglin Lin Cui,
Kimberley Lee
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0310
Subject(s) - medicine , breast cancer , hazard ratio , oncology , proportional hazards model , cancer , stage (stratigraphy) , disease , hormone receptor , confidence interval , paleontology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here